核苷(酸)类似物耐药变异对乙型肝炎病毒生物学特性的影响

被引:7
作者
陈立
张欣欣
机构
[1] 上海交通大学医学院附属瑞金医院感染科
关键词
肝炎病毒,乙型; 变异; 耐药;
D O I
暂无
中图分类号
R512.62 [];
学科分类号
100401 ;
摘要
引用
收藏
页码:1230 / 1232
页数:3
相关论文
共 21 条
[1]  
Identification and characterization of mutations in hepatitis B virus resistant to Lamivudine. Allex M L,Deslauriers M,Andrews C W,et al. Hepatology . 1998
[2]  
Overlapping gene mutations of hepatitis B virus in a chronic hepatitis B patient with hepatitis B surface antigen loss during lamivudine therapy. Lee SY,Choi MS,Lee D,et al. Journal of Korean Medical Science . 2005
[3]  
Clearance of the original hepatitis B virus YMDD-motif mutants with emergence of distinct lamivudine-resistant mutants during prolonged lamivudine therapy. Yeh CT,Chien RN,Chu CM,et al. Hepatology . 2000
[4]   Resistance to adefovir dipivoxil therapy associated with the selection of a novel mutation in the HBV polymerase [J].
Angus, P ;
Vaughan, R ;
Xiong, S ;
Yang, HL ;
Delaney, W ;
Gibbs, C ;
Brosgart, C ;
Colledge, D ;
Edwards, R ;
Ayres, A ;
Bartholomeusz, A ;
Locarnini, S .
GASTROENTEROLOGY, 2003, 125 (02) :292-297
[5]  
YSDD:a no-vel mutation in HBVDNApolymerase confers clinical resistance to lamivudine. Bozdayi AM,Uzunalimoglu O,Turkyilmaz AR,et al. Journal of Viral Hepatitis . 2003
[6]  
The polymerase L528M muta-tion cooperates with nucleotide binding-site mutations,increasing hepatitis B virus replication and drug resistance. Ono SK,Kato N,Shiratori Y,et al. The Journal of Clinical Investigation . 2001
[7]  
Emer-gence of a novel lamivudine-resistant hepatitis B virus va-riant with a substitution outside the YMDD motif. YATSUJI H,NOGUCHI C,HIRAGA N,et al. Antimicrobial Agents and Chemotherapy . 2006
[8]  
Variant of hepatitis B virus with primary resistance to adefovir. Schildgen O,Sirma H,Funk A,Olotu C,Wend UC,Hart- mann H,Helm M,Rockstroh JK,Willems WR,Will H,Gerlich WH. N Engl J Med . 2006
[9]  
Clinical emergence of entecavir-resistant hepatitis B virus requires additional substitutions in virus already resistant to Lamivudine. Tenney DJ,Levine SM,Rose RE,et al. Antimicrobial Agents and Chemotherapy . 2004
[10]  
Ente-cavir resistance is rare in nucleoside naive patients with hepatitis B. COLONNO RJ,ROSE R,BALDICK CJ,et al. Hepatology . 2006